I'm hosting some (live!) panels and firesides for our upcoming Boston biotech summit. Please join me there
I recently got word that Ronny Gal, the recently named chief strategy officer at Novartis, will be joining my lead live panel coming up in Boston next month. Which is, to use a technical phrase, really cool.
Gal made the leap from top Wall Street analyst — and someone I was always careful to read closely — to Novartis insider at a time the big player is reorganizing and rethinking how it works as a global pharma company. And I’m looking forward to picking his brains during our session, which will focus — in a variety of ways — on the key elements biotechs need to thrive in today’s none-too-copacetic environment.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.